Institutional Ownership
Elicio Therapeutics Inc
CUSIP 28657F103COMELTXQ1 2026
Institutional Holders
44
13F filers
Shares Held
2.05M
Aggregate institutional
Institutional Value
$21.66M
Q1 2026
Net New Holders
+9
16 new · 7 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions16
Increased13
Decreased6
Sold out7
Institutional Holders
44 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Knoll Capital Management, LLC | 630.9K | $6.74M | 0 | Held |
| 2 | Balyasny Asset Management L.P. | 244.8K | $2.62M | +106.1K | Added |
| 3 | Geode Capital Management, LLC | 135.2K | $1.45M | +2.6K | Added |
| 4 | Renaissance Technologies LLC | 121.6K | $1.30M | +93.5K | Added |
| 5 | Millennium Management LLC | 92.8K | $991.6K | +92.8K | New |
| 6 | Marshall Wace, LLP | 74.5K | $796.5K | −42.7K | Reduced |
| 7 | Susquehanna International Group, LLP | 70.8K | $756.9K | +6.8K | Added |
| 8 | Northern Trust Corp | 59.7K | $638.6K | +7.0K | Added |
| 9 | Goldman Sachs Group Inc | 57.8K | $618.1K | +57.8K | New |
| 10 | 683 Capital Management, LLC | 56.4K | $603.4K | 0 | Held |
34 more institutional holders on Premium
See every fund holding Elicio Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders